Clinical Practice Guidelines Updated for Primary Prevention of Stroke
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
MONDAY, Oct. 28, 2024 -- In a clinical guideline issued by the American Heart Association and American Stroke Association and published online Oct. 21 in Stroke, updated recommendations are presented for the primary prevention of stroke.
Cheryl Bushnell, M.D., from Wake Forest University in Winston-Salem, North Carolina, and colleagues conducted a systematic review to update guidelines for the primary prevention of stroke.
The authors note that to identify and achieve opportunities to promote brain health, every person should have access to and regular visits with a primary care health professional. In the approach to prevention of incident stroke, screening for and addressing adverse social determinants of health are important; in care settings where at-risk stroke patients may be evaluated, screening for social determinants of health is recommended. The Mediterranean diet pattern has been shown to reduce the risk for stroke, especially when supplemented with nuts and olive oil; low-fat diets have limited impact on reducing risk. For cardiovascular health and stroke risk reduction, physical activity is essential; an increased risk for stroke is seen in association with prolonged sedentary behavior. For patients with diabetes and high cardiovascular risk or established cardiovascular disease, glucagon-like protein-1 receptor agonists are recommended.
"Implementing the recommendations in this guideline would make it possible to significantly reduce the risk of people having a first stroke," Bushnell said in a statement. "Most strategies that we recommend for preventing stroke will also help reduce the risk of dementia."
Several authors disclosed ties to the pharmaceutical and medico-legal industries.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-10-29 12:00
Read more
- U.S. Food and Drug Administration Approves Perioperative Treatment of Neoadjuvant Opdivo (nivolumab) and Chemotherapy Followed by Surgery and Adjuvant Single-Agent Opdivo for Resectable Non-Small Cell Lung Cancer (NSCLC)
- UCB Receives U.S. FDA Approval for 320 mg Single-Injection Device Presentations of Bimzelx (bimekizumab-bkzx)
- 2023 Cisplatin Shortage Tied to Use of Alternatives for Head, Neck Cancer
- Seniors Who Split: Rates of 'Gray Divorce' Have Tripled Since 1990
- AAO: Prior Intravitreal Injections Increase Risk for Cataract Surgery Complications
- Could Lingering Infection Be Causing Long COVID?
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions